Literature DB >> 2338656

Effects of desipramine maintenance on cocaine self-administration by humans.

M W Fischman1, R W Foltin, G Nestadt, G D Pearlson.   

Abstract

Six research volunteers with histories of cocaine use were tested in a cocaine choice paradigm to investigate the effects of desipramine maintenance on cocaine-taking behavior. Subjects were allowed to self-administer i.v. saline or cocaine (8, 16 or 32 mg) in daily 3-hr sessions to establish baseline levels of self-administration, self-reported effects of the drug and changes in heart rate and blood pressure. Each subject was then maintained on daily doses of desipramine for 3 to 4 weeks, after which a second cocaine self-administration dose-response curve was generated under desipramine maintenance. This maintenance had no effect on cocaine self-administration. There was, however, a significant increase in heart rate and blood pressure during desipramine maintenance. Desipramine maintenance also resulted in a change in the profile of cocaine's self-reported effects. In some cases (e.g., Arousal and Vigor on the Profile of Mood States, Benzedrine Group scale on the Addiction Research Center Inventory), reports of cocaine's effects were significantly reduced under conditions of desipramine maintenance, and in others (e.g., Anxiety, Anger and Confusion on the Profile of Mood States), those reports were significantly increased. Furthermore, there was a significant decrease in subjects response to an "I want cocaine" question while under desipramine maintenance. The data suggest that desipramine does not affect the reinforcing properties of cocaine, but may interfere with its other stimulus properties. Furthermore, the cardiovascular effects of desipramine appear to have the potential for toxicity when that drug is administered in combination with cocaine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338656

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

1.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

2.  Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine.

Authors:  P M Callahan; M F Piercey; K A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIES.

Authors:  N K Mello
Journal:  NIDA Res Monogr       Date:  2005-05

Review 4.  A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming.

Authors:  James J Mahoney; Ari D Kalechstein; Richard De La Garza; Thomas F Newton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-01-31       Impact factor: 5.067

Review 5.  Challenges for translational psychopharmacology research--some basic principles.

Authors:  Klaus A Miczek; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2008-06-05       Impact factor: 4.530

Review 6.  The role of human drug self-administration procedures in the development of medications.

Authors:  S D Comer; J B Ashworth; R W Foltin; C E Johanson; J P Zacny; S L Walsh
Journal:  Drug Alcohol Depend       Date:  2008-04-24       Impact factor: 4.492

7.  Monoamine uptake inhibitors alter cocaine pharmacokinetics.

Authors:  S R Tella; S R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Authors:  Margaret Haney
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

9.  The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

Authors:  R De La Garza; J J Mahoney; C Culbertson; S Shoptaw; T F Newton
Journal:  Pharmacol Biochem Behav       Date:  2008-01-22       Impact factor: 3.533

Review 10.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.